Natural Alternative Sweeteners Could Tap up to 25% of Key Markets for Sucrose
Tagatose and others have huge potential as consumption of sugar and sweeteners rises 30% to 292 million metric tons in 2024, according to Lux Research
Today, alternative sweeteners account for 22% of the total sweetener market, but natural sweetener alternatives represent only 1% of the sweetener market. Recent attention has focused on three nascent natural alternative sweeteners – tagatose, derived from dairy; mogroside V, extracted from monk fruit; and brazzein, a sweet protein which comes from the oubli plant. Alternatives like these have the potential to replace between 2% and 25% of total sucrose across product categories like bakery and cereal, beverage, and confection.
“Sucrose remains nearly impossible to fully mimic, and no one alternative sweetener provides a magic bullet. Consequently, a good strategy for developers is to combine several and derive a higher%age of functionalities,” said Camilla Stice, Lux Research Analyst and lead author of the report titled, “Natural Alternative Sweeteners: Assessing the True Addressable Market.”
“Developers must also recognize several additives needed for reformulation and consider the additive costs, rather than focus on the sole cost of the replacement sweetener,” she added.
Lux Research analysts studied the market opportunity for three natural alternative sweeteners. Among their findings:
• Each sweetener functionally capable of replacing over 10 MMT sugar globally. Tagatose has the potential to replace 31 MMT of sugar used worldwide while mogroside V and brazzein could replace 10 MMT and 13 MMT, respectively. To reach these levels of replacement, developers must successfully produce 34 MMT tagatose while much less of mogroside V (45,000 MT) and brazzein (12,500 MT) is required due to the compounds’ high sweetness intensity.
• Current production falls short. Production volumes of nascent natural alternative sweeteners are low or virtually non-existent on account of high-priced feedstock, low yields, scarce growth, and costly extraction processes. To reach full potential, developers must increase production of mogroside V by 200-fold and successfully scale production of tagatose and brazzein for market entry.
• New production technologies hold promise yet development hurdles pose challenges. The lure of capitalizing on sucrose’s bad name brings several production technologies to bat, including synthetic biology, enzymatic transformation, and biopharming techniques. However, no current solution successfully delivers adequate sweetener volumes. Developers must address massive scale up challenges before these alternative sweeteners become a mass-market reality.